| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.9M | -57.8% |
| R&D Expense | $85.7M | +27.7% |
| SG&A Expense | $46.5M | +6.4% |
| Operating Income | -$116.4M | -59.0% |
| Interest Expense | $4.9M | +1617.4% |
| Pre-tax Income | -$129.6M | -62.9% |
| Income Tax | $0 | — |
| Net Income | -$129.6M | -62.9% |
| EPS (Basic) | -$2.87 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.5M | -16.1% |
| Current Assets | $154.3M | -15.8% |
| Total Assets | $318.2M | -0.6% |
| Current Liabilities | $82.1M | +20.5% |
| Total Liabilities | $200.5M | +48.8% |
| Stockholders' Equity | $117.7M | -36.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.1M | -594.2% |
| Capital Expenditures | $45.0M | -3.0% |
| Investing Cash Flow | -$45.0M | +27.1% |
| Financing Cash Flow | $95.2M | +5473.8% |
| Free Cash Flow | -$118.1M | -107.6% |
| -59.4% |
| EPS (Diluted) | -$2.87 | -59.4% |